Truist Securities Maintains Buy on MannKind, Lowers Price Target to $5

Benzinga Newsdesk www.benzinga.com Negative 57.2%

Neg 57.2% Neu 0% Pos 0%

Truist Securities analyst Gregory Renza maintains MannKind (NASDAQ:MNKD) with a Buy and lowers the price target from $6 to $5.